Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Shares Purchased: 175,642 ordinary shares for cancellation.
- Purchase Date: August 21, 2025.
- Price Range: Highest price paid was 366.00 pence; lowest was 365.10 pence.
- Volume Weighted Average Price: 365.6259 pence per share.
- Post-Transaction Capital: Registered share capital stands at 8,970,696,108 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205 shares held as treasury shares.
- Voting Rights: 8,966,815,903 ordinary shares with voting rights.
Material Changes
This transaction represents the second tranche of the share buyback programme announced on July 31, 2025. The purchase reduced the number of shares held as treasury stock and adjusted the total count of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital transaction.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the current share buyback programme.
- Review the full breakdown of individual trades available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates on the company's overall capital structure and treasury share holdings.